| Epigenetic and non-epigenetic regulation of Klotho in kidney disease A Kale, H Sankrityayan, HJ Anders, AB Gaikwad Life sciences 264, 118644, 2021 | 53 | 2021 |
| Evidence for use or disuse of renin–angiotensin system modulators in patients having COVID-19 with an underlying cardiorenal disorder H Sankrityayan, A Kale, N Sharma, HJ Anders, AB Gaikwad Journal of Cardiovascular Pharmacology and Therapeutics 25 (4), 299-306, 2020 | 26 | 2020 |
| Klotho: A possible mechanism of action of SGLT2 inhibitors preventing episodes of acute kidney injury and cardiorenal complications of diabetes A Kale, H Sankrityayan, HJ Anders, AB Gaikwad Drug Discovery Today 26 (8), 1963-1971, 2021 | 23 | 2021 |
| Receptor-mediated mitophagy: An emerging therapeutic target in acute kidney injury N Dagar, A Kale, S Steiger, HJ Anders, AB Gaikwad Mitochondrion 66, 82-91, 2022 | 18 | 2022 |
| How to use COVID-19 antiviral drugs in patients with chronic kidney disease A Kale, V Shelke, N Dagar, HJ Anders, AB Gaikwad Frontiers in pharmacology 14, 1053814, 2023 | 15 | 2023 |
| Epigenetic restoration of endogenous Klotho expression alleviates acute kidney injury-diabetes comorbidity A Kale, H Sankrityayan, AB Gaikwad Life Sciences 288, 120194, 2022 | 15 | 2022 |
| Role of SET7/9 in the progression of ischemic renal injury in diabetic and non-diabetic rats N Sharma, H Sankrityayan, A Kale, AB Gaikwad Biochemical and Biophysical Research Communications 528 (1), 14-20, 2020 | 14 | 2020 |
| Klotho in kidney diseases: a crosstalk between the renin–angiotensin system and endoplasmic reticulum stress A Kale, H Sankrityayan, HJ Anders, AB Gaikwad Nephrology Dialysis Transplantation 38 (4), 819-825, 2023 | 12 | 2023 |
| Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity A Kale, V Shelke, H Sankrityayan, N Dagar, AB Gaikwad Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (12), 166532, 2022 | 12 | 2022 |
| Lupus Nephritis: New and Emerging Biologic and Targeted Therapies A Kale, M Lech, HJ Anders, AB Gaikwad BioDrugs 37 (4), 463-475, 2023 | 11 | 2023 |
| Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease V Shelke, A Kale, HJ Anders, AB Gaikwad Journal of Molecular Medicine 100 (7), 1017-1026, 2022 | 10 | 2022 |
| Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells H Sankrityayan, A Kale, V Shelke, AB Gaikwad Archives of Physiology and Biochemistry 130 (4), 411-419, 2024 | 9 | 2024 |
| Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease T Habshi, V Shelke, A Kale, HJ Anders, AB Gaikwad Journal of Cellular Physiology 238 (1), 82-93, 2023 | 9 | 2023 |
| Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury V Shelke, A Kale, N Dagar, T Habshi, AB Gaikwad Food & Function 14 (11), 5391-5403, 2023 | 8 | 2023 |
| Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease V Shelke, A Kale, HJ Anders, AB Gaikwad Molecular and Cellular Biochemistry 478 (9), 1987-1998, 2023 | 6 | 2023 |
| Hippo signaling in acute kidney injury to chronic kidney disease transition: Current understandings and future targets T Habshi, V Shelke, A Kale, M Lech, AB Gaikwad Drug Discovery Today 28 (8), 103649, 2023 | 6 | 2023 |
| Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease V Shelke, A Kale, H Sankrityayan, HJ Anders, AB Gaikwad Archives of Physiology and Biochemistry 130 (2), 230-241, 2024 | 5 | 2024 |
| Voclosporin: unique chemistry, pharmacology and toxicity profile, and possible options for implementation into the management of lupus nephritis A Kale, V Shelke, Y Lei, AB Gaikwad, HJ Anders Cells 12 (20), 2440, 2023 | 5 | 2023 |
| Evaluating the potential of tauroursodeoxycholic acid as add-on therapy in amelioration of streptozotocin-induced diabetic kidney disease H Sankrityayan, V Shelke, A Kale, AB Gaikwad European Journal of Pharmacology 942, 175528, 2023 | 5 | 2023 |
| Phloretin: a comprehensive review of its potential against diabetes and associated complications V Shelke, A Kale, YA Kulkarni, AB Gaikwad Journal of Pharmacy and Pharmacology 76 (3), 201-212, 2024 | 4 | 2024 |
Dr Gaikwad Anil BhanudasAssociate Professor, Department of Pharmacy Birla Institute of Technology and Science, Pilani在 pilani.bits-pilani.ac.in 的电子邮件经过验证
